Valuation
- Market cap
- —
- Revenue TTM
- —
- Net income TTM
- —
- PE ratio
- —
- Forward PE
- —
- Profit margin
- —
- Debt to equity
- —
Trading
- Volume
- 6,770,373
- Avg volume
- —
- Day's range
- $9.99 – $10.03
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Eur...
Show more
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
- Industry
- Shell Companies
- Sector
- Financial Services
- Phone
- 213 830 6300
- Website
- https://www.oaktreeacquisitioncorp.com/oac-iii
- Address
- 333 South Grand Avenue, 28th Floor, Los Angeles, United States
Latest news
No headlines yet.
